Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPRES: Upstream Atorvastatin in STEMI
NCT01050348Phase 4Completed
- Sponsor
- West Penn Hospital
- Start
- Jun 2009
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of atorvastatin in ST elevation myocardial infarction (STEMI) (2 arms), sponsored by West Penn Hospital. Primary endpoint: Major Adverse Cardiovascular Event at 30 days. Started Jun 2009; status: completed.
02
Drugs
atorvastatin
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT01050348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01050348.